Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 27, 01:38 AM 2012  
VRX HSP ALKS PETS ACUR FLML 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for ELN

Elan story

    
    

Elan Corporation plc

 Stock@American Stock Exchange 
United States
    
Use Elan Corporation plc story together with your portfolio to enhance returns of your portfolios and to determine Stock optimization strategy that fits your criteria.
    
    

Elster Group SE Reaffirms FY 2011 Guidance


Reuters Key Development - Nov 3, 2011

Story Momentum

    
This story from stocks.us.reuters.com contributed to next trading day price increase. The story delta to the next closing price was 0.25% . The story delta to the current price is 11.70% . story delta up: ELN
Price
 
Timeline

Similar stores for Elan

    
Few days ago at www.businessweek.com      

Cancer Tools Help Roche Push Ahead With Alzheimer's Drug

By Naomi Kresge on May 14, 2012 Roche Holding AG (ROG) is focusing part of its pipeline on the riskiest area of drug development: the human brain.
Few days ago at www.thestreet.com      

A Health Care Fortnight for the Record Books

By Nathan Sadeghi-Nejad 05/14/12 - 07:00 AM EDT NEW YORK (TheStreet) -- I've been a professional investor for 15 years, and over that time I've listened to generalist investors gripe about the health care sector with mind-numbing cyclicality.
Few days ago at www.streetinsider.com      

Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics ...

Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics ... StreetInsider.com (subscription) - May 11, 2012 Alzheimer's Disease - Disease modifying agents that produce modest disease progression delay could still be approved and widely used.
    
    

Discuss Elan story

       
       
    
Follow Elan News with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Elan to your reader
 
Get social with Elan News
 Elan News 
Share Toggle social options for Elan News
    

Elan Research Report

    
    

Current Valuation Comparison

Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting